Effectiveness of Physiotherapy Interventions for Patients With Parkinson's Disease

March 9, 2010 updated by: Queen Elizabeth Hospital, Hong Kong

The Effectiveness of Physiotherapy Interventions in Patients With Parkinson's Disease, a Randomized Controlled Trial

Parkinson's Disease is an incurable and progressive disease. Treatment includes medication and non-pharmacological intervention such as physiotherapy. Physiotherapy is a main component of non-pharmacological interventions. It includes exercise to strengthen the muscles; improves balance and walking, and adopts the use of visual cue training. Treatment has been found to be effective in patients with mild impairment up to 6 months post-treatment. The present study will investigate the effectiveness of treatment for patients with mild to moderate impairment for short term (3-month) and long term (1 year). The hypothesis is that compared to patient education alone, physiotherapy intervention for patients with Parkinson's disease leads to improve function and quality of life.

Study Overview

Detailed Description

Parkinson's disease (PD) is an incurable and progressive disease (Rubenis 2007). Current management include medical, neuro-surgical and non-pharmacological intervention. Physiotherapy is a major component in non-pharmacological interventions. Effective interventions including visual or auditory cues improves gait (Nieuwboer et al. 2007), exercise is effective in improving balance (Hirsch et al 2003); intense treadmill training improves motor control, quality of life and walking speed so as to sustain improvement in gait speed and motor control post 4 weeks of treatment (Herman et al 2007). Patient with PD attending physiotherapy twice weekly, one and half hour for 12 weeks showed improvement in walking speed and Activities of Daily Living (Ellis et al 2005). However, the majority of focus on patients in the Hoehn and Yahr stage of 2 to 3 and long term effect is lacking (Kwakkel et al 2007). A knowledge gap is present in the effectiveness of physiotherapy training of patients with Parkinson's disease in the more advanced stage of disease and long term effect is lacking. The aim of the study is to investigate the immediate, short-term & long-term clinical effects of physiotherapy training of patients with Parkinson's disease. The hypothesis is that compared to patient education alone, physiotherapy intervention for patients with Parkinson's disease leads to improve function and quality of life.

Study Type

Interventional

Enrollment (Anticipated)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kowloon, Hong Kong
        • Recruiting
        • Queen Elizabeth Hospital
        • Contact:
        • Sub-Investigator:
          • YF Cheung, Dr
        • Sub-Investigator:
          • HF Chan, Dr
        • Sub-Investigator:
          • HM Chan, Dr
        • Sub-Investigator:
          • MY Lau, Dr
        • Sub-Investigator:
          • HS Chan
        • Sub-Investigator:
          • HF Mak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Stable medication usage
  • Hoehn and Yahr stage II to IV
  • At least 1 score of 2 or more for at least 1 limb of either the tremor, rigidity, or bradykinesia item of the Unified Parkinson's Disease Rating Scale (UPDRS)
  • Able to walk independently
  • No severe cognitive impairments (Mini-Mental State Examination - Chinese Cantonese version) score greater than 24

Exclusion Criteria:

  • Other severe neurological, cardiopulmonary, or orthopedic disorders
  • Having participated in a physiotherapy or rehabilitation program in previous 2 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physiotherapy Interventions
Physiotherapy Interventions including strengthening exercise, balance training, gait training with visual cue, gait training with treadmill.
Physiotherapy interventions including strengthening exercise, balance training, gait training with visual cus and gait training with treadmill
Other: Education
Education Classes
Other Names:
  • Education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Movement Disorder Society-Unified Parkinson's Disease Rating Scale
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Levodopa equivalent daily dosage (LEDD)
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up and Go Test
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Activities-Specific Balance Confidence Scale (Chinese version)
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Parkinson's Disease Questionnaire (Standard Chinese Version)
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Parkinson's Disease Questionnaire (Standard Chinese Version) - PDQ-39 (Chinese)
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Number of Injurious Falls
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: CW WOO, Physiotherapy Department, Queen Elizabeth Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2010

Primary Completion (Anticipated)

October 1, 2012

Study Completion (Anticipated)

October 1, 2012

Study Registration Dates

First Submitted

February 25, 2010

First Submitted That Met QC Criteria

February 25, 2010

First Posted (Estimate)

February 26, 2010

Study Record Updates

Last Update Posted (Estimate)

March 10, 2010

Last Update Submitted That Met QC Criteria

March 9, 2010

Last Verified

March 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Physiotherapy Interventions

3
Subscribe